IRIS PubliCatt

Orlandi, Armando
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.027
EU - Europa 1.653
AS - Asia 517
AF - Africa 40
SA - Sud America 7
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.251
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.015
DE - Germania 419
SE - Svezia 412
IT - Italia 254
CN - Cina 182
SG - Singapore 158
IE - Irlanda 119
PL - Polonia 105
FR - Francia 72
ID - Indonesia 70
GB - Regno Unito 69
RU - Federazione Russa 54
UA - Ucraina 49
CI - Costa d'Avorio 37
FI - Finlandia 34
IN - India 25
HK - Hong Kong 22
TR - Turchia 22
BE - Belgio 16
IR - Iran 16
CA - Canada 11
CH - Svizzera 8
JP - Giappone 8
VN - Vietnam 8
ES - Italia 7
NL - Olanda 7
BR - Brasile 6
CZ - Repubblica Ceca 6
RS - Serbia 5
AU - Australia 4
LU - Lussemburgo 4
RO - Romania 3
EU - Europa 2
KR - Corea 2
MA - Marocco 2
NO - Norvegia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BG - Bulgaria 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
KZ - Kazakistan 1
MD - Moldavia 1
MX - Messico 1
PK - Pakistan 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.251
Salva come PNG Salva come JPEG
Città #
Chandler 487
Ashburn 181
Singapore 114
Dublin 113
Warsaw 103
New York 87
Fairfield 78
Jakarta 69
Wilmington 65
Houston 64
San Mateo 64
Rome 59
Ann Arbor 48
Princeton 47
Woodbridge 47
Boston 46
Moscow 42
Nanjing 39
Abidjan 37
Chicago 36
Milan 36
Seattle 35
Cattolica 34
Jacksonville 33
Cambridge 32
Dearborn 29
Redwood City 28
Marseille 26
London 22
Izmir 21
Nürnberg 21
Beijing 19
Helsinki 18
Bremen 16
Hong Kong 16
Brussels 14
Nanchang 13
Lawrence 12
Boardman 11
Los Angeles 11
Hangzhou 10
Mountain View 10
Munich 10
Fremont 9
San Diego 9
Toronto 9
Washington 9
Andover 8
Augusta 8
Dong Ket 8
Norwalk 8
Pescara 7
Bari 6
Falls Church 6
Guangzhou 6
Hebei 6
Hefei 6
Kish 6
Leawood 6
Pune 6
Shenyang 6
Belgrade 5
Berlin 5
Busto Arsizio 5
Millbury 5
Zurich 5
Amsterdam 4
Caserta 4
Changsha 4
Clearwater 4
Kunming 4
Madrid 4
Palermo 4
Paris 4
Redmond 4
Santa Clara 4
Acton 3
Brno 3
Detroit 3
Florence 3
Lappeenranta 3
Montesilvano Marina 3
Northbrook 3
Rio De Janeiro 3
Sacramento 3
San Francisco 3
Tianjin 3
Zhengzhou 3
Bassano del Grappa 2
Binetto 2
Frankfurt am Main 2
Islington 2
Jiaxing 2
Krakow 2
Lancaster 2
Landshut 2
Legnano 2
Manchester 2
Monmouth Junction 2
Mumbai 2
Totale 2.557
Salva come PNG Salva come JPEG
Nome #
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 249
Diagnosis and management of breast lymphoma: A single-institution retrospective analysis 187
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 180
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 159
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 146
Mastectomy in precision oncology era: Myth or reality? 143
AMAROS Study: Overall Survival in Breast Cancer Subtypes 107
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 105
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 102
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 102
Trastuzumab-induced corneal ulceration: successful no-drug treatment of a "blind" side effect in a case report 98
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 91
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 89
Menopausal hormone therapy: What should be kept in mind for a personalized choice in a shared decision-making 81
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 78
Paradox CA 15-3 increase in metastatic breast cancer patients treated with everolimus: A change of paradigm in a case series 76
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 74
Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer: Preliminary experience with clinically node negative patients after systemic treatment 71
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 69
Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis 68
ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas 67
LUX-Lung 7: is there enough data for a final conclusion? 66
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 66
Neoadjuvant chemotherapy in breast cancer: An advanced personalized multidisciplinary prehabilitation model (apmp-m) to optimize outcomes 66
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 64
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 63
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies 63
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 62
Diffuse liver infiltration by lobular breast carcinoma: Shear wave elastography as gold standard imaging study. 60
OlympiAD trial: moving to a next level of treatment for patients with BRCA mutation and her2-negative metastatic breast cancer 59
Let‐7a‐5p, mir‐100‐5p, mir‐101‐3p, and mir‐199a‐3p hyperexpression as potential predictive biomarkers in early breast cancer patients 57
Immediate prosthetic breast reconstruction after nipple-sparing mastectomy: Traditional subpectoral technique versus direct-to-implant prepectoral reconstruction without acellular dermal matrix 56
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience 56
A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer 56
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analisys 54
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 54
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 52
Class 1, 2, and 3 BRAF-mutated metastatic colorectal cancer: A detailed clinical, pathologic, and molecular characterization 52
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 52
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 52
Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020 49
Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA 49
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 48
Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-Analysis 48
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 47
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis 45
Bevacizumab-based neoadjuvant chemotherapy for colorectal cancer liver metastases: Pitfalls and helpful tricks in a review for clinicians 44
Neoadjuvant Chemotherapy in Breast Cancer: An Advanced Personalized Multidisciplinary Prehabilitation Model (APMP-M) to Optimize Outcomes 43
Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial 43
Usefulness of automated breast volume scanner (ABVS) for monitoring tumor response to neoadjuvant treatment in breast cancer patients: preliminary results 42
Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors 39
How will artificial intelligence impact breast cancer research efficiency? 37
Association between background parenchymal enhancement and tumor response in patients with breast cancer receiving neoadjuvant chemotherapy 35
A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer 34
Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope 32
New life for retrospective study in the precision oncology era 32
Targeted therapy in advanced gastric carcinoma: The future is beginning 25
To treat or no to treat: HER2 equivocal is the matter! 22
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth 22
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysis 21
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience 21
PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives 19
Definition of a tool to assess shared decision-making (SDM) on women with breast cancer: A value-based approach 19
New challenges in multimodal workout of locally advanced breast cancer 19
Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2 14
The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer 12
Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study 12
An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant Chemotherapy 10
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 8
Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting 8
Racial and ethnic disparities in breast cancer survival: critical appraisal of the data emerging from the randomized TAILORx 3
Totale 4.354
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.423
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.423
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020277 0 0 0 13 37 47 49 19 22 19 52 19
2020/2021417 13 27 14 44 93 32 47 4 42 30 49 22
2021/2022657 59 11 10 67 18 50 18 83 34 41 131 135
2022/20231.395 188 194 99 197 79 142 90 135 145 40 52 34
2023/2024748 40 164 30 34 38 151 53 43 16 19 75 85
2024/2025229 37 28 135 29 0 0 0 0 0 0 0 0
Totale 4.354